ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation’s ...
Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...
ImmunityBio (IBRX) announced U.S. Urology Partners, one of the nation’s largest independent providers of urology and related specialty ...
Nadofaragene firadenovec intravesical gene therapy continues to show promise in treating BCG-unresponsive NMIBC bladder cancer.
MedTrainer, a leading provider in healthcare workforce compliance solutions, is the winner of two Stevie® Awards for Sales & Customer Service. MedTrainer's customer support team is setting a new ...
Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its fourth quarter and full ...
ET Now on MSN21h
Aurobindo's CuraTeq Biologics Aims Doubling Down on Biosimilar Launches - 2031 Plans REVEALED | ET NOW On The Go Hyderabad EditionAurobindo, that last year signed a deal with U.S. drugmaker MSD to manufacture one of their biologics products at its ...
Opinion
The Star on MSN17hOpinion
MONICAH OTIENO: Solutions to TB, HIV benefit all of us - North and SouthIn the west of Kenya, near the shores of Lake Victoria, where I come from, a tuberculosis outbreak is no different from one that takes place anywhere else in the world. A few dozen people get sick, ...
Ocado revealed on Thursday that chairman Adam Warby had acquired 100,000 ordinary shares in the FTSE 250-listed firm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback